Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OEQ Validation with Symbicort vs Budesonide in Asthma
NCT00449501Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Mar 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of budesonide + formoterol in asthma (2 arms), sponsored by AstraZeneca. Primary endpoint: Onset of Effect Questionnaire items 2 and 5 response. Started Mar 2007; status: completed.
02
Drugs
budesonide + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00449501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00449501.